Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • NTRA vs GSK✓SelectedUSD · GSKNTRA vs GSK performance historyLatest closeAs of+0.71%11/18
Stock and ETF performance explorer

NTRA vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+428.4%
GSK return
+56.0%
Excess return
+372.4%
Maximum drawdown
-34.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+0.7%-1.3%+2.0%+0.9%
7D-9.5%-3.1%-6.4%-9.1%
30D-27.5%-0.9%-26.6%-27.5%
3M-7.1%-4.2%-3.0%-6.7%
6M+50.4%-1.6%+51.9%+50.3%
YTD+26.4%+2.6%+23.8%+25.8%
1Y+35.5%+6.2%+29.3%+34.3%
All+428.4%+56.0%+372.4%+381.7%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling